...Aditya K. Gupta; Vasiliki Economopoulos Introduction: Alopecia areata (AA) is a difficult to treat and appearance altering disorder affecting up to 2% of people during their lifetime. Understanding current management trends will help in improving patient outcomes. The aim of this study...

...Thomas Stirrat; Sach Thakker; Deeptha Bejugam; Carolyn Goh; Shari R. Lipner Background: Upadacitinib, a selective Janus kinase (JAK) 1 inhibitor, has demonstrated promising efficacy in alopecia areata (AA), particularly in patients unresponsive to conventional therapies. As JAK inhibitors gain...

... suggested potential benefits in promoting hair growth and treating various forms of HL. These remedies were found to be effective in different conditions, including androgenetic alopecia, telogen effluvium, and alopecia areata, through various mechanisms of action, including 5α-reductase inhibition...

... of primary cutaneous T-cell lymphoma, can present with diverse clinical manifestations, including alopecia that mimics conditions such as alopecia areata (AA) and lichen planopilaris (LPP). The folliculotropic variant (FMF) poses diagnostic challenges due to overlapping clinical features, necessitating...

...Li-Chi Chen; Chino Ogbutor; Kristen J. Kelley; Maryanne M. Senna Background: Alopecia areata (AA) is an autoimmune disease characterized by non-scarring hair loss that can affect children, adolescents, and adults. Ritlecitinib, an orally administered Janus kinase (JAK) 3/tyrosine kinase expressed...

...A.E. Soliman; Olfat Shaker; Samar M. El-Tahlawi; Ghada Abdaltwab Mahgoub; Sara M. Yaseen Introduction: Alopecia areata (AA) is an immune-mediated disease characterized by non-scaring hair loss. High levels of FABP4 have been implicated in different inflammatory diseases. We aim to assess...

...Mayra A. Reyes Soto; Rodrigo Pirmez Introduction: Alopecia areata incognita (AAI) remains a subject of ongoing debate in the literature, with some authors advocating its classification as a subtype of alopecia areata. A localized form of this condition, entitled circumscribed AAI, has been rarely...

...Alexandros Katoulis; Georgia Pappa; Effie Markou; Antonios Kanelleas; Evangelia Bozi; Dimitrios Sgouros; Dimitris Rigopoulos; Lidia Rudnicka Introduction: Alopecia areata exhibits diverse clinical forms, encompassing the less common variant, sisaipho. Clinical observations suggest its unique...

...Athanasios J. Stefanis; Alena Fialova; Petr Arenberger Introduction: Alopecia areata (AA) is associated with thyroid dysfunction and abnormal levels of thyroglobulin and thyroid peroxidase autoantibodies. One study detected high prevalence of thyrotropin receptor antibodies (TRAbs) in AA patients...

...Kaya L. Curtis; Onajia Stubblefield; Shari R. Lipner Introduction: Previous studies have demonstrated association of alopecia areata (AA) with anxiety and depression. However, few case-control studies have evaluated AA association with posttraumatic stress disorder and lifestyle factors, including...

...Luciana Gasques; Fernanda Freitas de Brito; Raissa Zobiole; Letícia Bortolini; Vanessa Catalá Casteli Assumpção; Caio Leal Carvalho Alopecia areata (AA) is a disease with a great impact on quality of life of patients. Among several treatment modalities, intralesional injectable corticosteroid...

... transcutaneously and exposed indirectly to ingested and inhaled pollutants via the bloodstream. Summary: Some pollutants, such as particulate matter, trigger inflammatory responses and have been associated with alopecia areata. Others, like tobacco smoke and phthalates, exert endocrine effects with unclear...

...Malak M. Almutlq; Abrar E. Bukhari Alopecia areata (AA) is an autoimmune condition that causes non-scarring hair loss on the scalp or other hair-bearing surfaces. Various signalling molecules regulate the hair cycle and hair follicle regeneration. These include genes, growth factors, nuclear...

...Elva Dalia Rodríguez-Acosta; Diego Fernandez Nieto; Emilio Berna-Rico; Hector Ricardo Galván-García; Ruth Galit Meza-Castro; Ana Karen Rosales-Lerma; Andrea Viridiana Guerrero-Cervantes; Hassiel Aurelio Ramírez-Marín Introduction: Alopecia areata (AA) is an autoimmune disease characterized by T...

... loss in conditions secondary to autoimmune dysfunction. Lichen planopilaris (LPP), frontal fibrosing alopecia (FFA), and alopecia areata (AA) are hair disorders with underlying autoimmune components and no standardized treatment guidelines. We summarized the available literature on the use of HCQ...

...Ogechi Ezemma; Shivali Devjani; Balaji Jothishankar; Kristen J. Kelley; Maryanne Senna Background: Alopecia areata (AA) is a chronic autoimmune disease that causes non-scarring alopecia. A few studies have shown increased odds of AA in Black individuals compared to White individuals and increased...

...Sara J. Li; Sophia Reyes-Hadsall; Lara Drake; Kathie Huang; Arash Mostaghimi Introduction: Alopecia areata (AA) is an immune-mediated hair loss condition with substantial psychosocial impact. The impact of AA on social interactions at work has not been established. Methods: We administered...

...Lara Drake; Sara J. Li; Sophia Reyes-Hadsall; Karen Lee; Kathie Huang; Arash Mostaghimi Introduction: Alopecia areata (AA) is an autoimmune condition that results in nonscarring hair loss. AA is comorbid with mental health disorders including anxiety and depression. This study aimed to evaluate...

...Noha Mohamad; Ahmed M.B. Khedr; Olfat Gamil Shaker; Mohammed Hassan Introduction: Alopecia areata (AA) is a common autoimmune condition that affects anagen hair follicles. The most commonly recognized theory is that it is a T-cell-mediated autoimmune disorder in a genetically susceptible individual...

...Lara Drake; Jane Han; Sophia Reyes-Hadsall; Arash Mostaghimi; Kathie Huang Introduction: Alopecia areata (AA) is an autoimmune condition that results in nonscarring hair loss. There is currently only one Food and Drug Administration (FDA)-approved treatment for AA; as a result, a wide range...